ArticleEye (London, England)2025
Associations between obstructive sleep apnoea and the development and severity of retinal vein occlusion.
Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Herpes zoster as a vaccine-preventable risk factor increases the risk of dementia: A nested case-control study in Chinese population.Human vaccines & immunotherapeutics · 2026Article
- Comment on: 'Associations between obstructive sleep apnoea and the development and severity of retinal vein occlusion'.Eye (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
BACKGROUND/
objectivesEmerging research suggests obstructive sleep apnoea (OSA) as a potential risk factor for retinal vein occlusion (RVO), but the impact of sex, race, and ethnicity, and the role of OSA in RVO progression, remains unclear. This study explored demographic differences in the association between OSA and RVO and compared the severity of RVO in patients with and without OSA. SUBJECTS/
methodsThis retrospective cohort study analysed aggregated, de-identified electronic health record data of US patients. Adults who received ophthalmological services were grouped by baseline RVO status (RVO-naïve and preexisting RVO). The RVO-naïve group was further stratified by sex, race, and ethnicity. Patients with and without OSA were compared within each group to evaluate the risk ratio for primary outcomes: new RVO diagnoses in RVO-naïve individuals and RVO complications or invasive treatments in those with preexisting RVO.
resultsAmong RVO-naïve adults, OSA was associated with an increased risk of RVO in females (n = 148,036, RR = 1.28, CI = 1.14-1.45), males (n = 134,348, RR = 1.35, CI = 1.19-1.52), non-Hispanic White (n = 146,124, RR = 1.32, CI = 1.17-1.49), Hispanic/Latino (n = 30,898, RR = 1.77, CI = 1.30-2.40) patients. A marginally increased risk was seen in Black patients (n = 57,798, RR = 1.26, CI = 1.05-1.50), but not in Asian patients (n = 6860, RR = 1.21, CI = 0.71-2.07). Among 5264 adults with preexisting RVO, those with OSA had higher rates of macular oedema (RR = 3.70, CI = 3.17-4.31), vitreous haemorrhage (RR = 2.29, CI = 1.64-3.20), neovascularization (RR = 2.22, CI = 1.69-2.91), and photocoagulation (RR = 1.73, CI = 1.29-2.33), but not vitrectomy (RR = 1.13, CI = 0.74-1.72).
conclusionsOSA is associated with an increased risk of RVO among various populations, especially among Hispanic/Latino. Among patients with preexisting RVO, OSA is associated with indicators of more severe RVO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.